Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1412140-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI M701TVIL1412140J1), received between May 3, 2017 and Jan 6, 2022 — classified as 7 injuries.
The most frequently reported specific device problem is “Unintended Movement” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Unintended Movement3
- Appropriate Device Problem Term/Code Not Available1
- Insufficient Device Problem Information1
- Leak/Splash1
- Occlusion Within Device1
- Off-Label Use1
- Partial Blockage1
- Patient-Device Incompatibility1
Patient problems
- Failure of Implant5
- Aneurysm3
- Occlusion1
- Pain1
- Vascular Dissection1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryJan 6, 2022Off-Label Use; Unintended Movement; Appropriate Device Problem Term/Code Not Available; Off-Label Use; Unintended Movement; Appropriate Device Problem Term/Code Not Available
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX STENT GRAFT SYSTEM. APPROXIMATELY THREE (3) YEARS POST INITIAL PROCEDURE A TYPE IA ENDOLEAK, AND A TYPE IB ENDOLEAK WERE IDENTIFIED DURING ROUTINE FOLLOW-UP. SUCCESSFUL REINTERVENTION WAS PERFORMED WITH IMPLANT OF AN PALMAZ (NON-ENDOLOGIX) TO TREAT THE TYPE IA ENDOLEAK AND AN OVATION EXTENDER TO TREAT THE TYPE IB ENDOLEAK. THE PATIENT WAS REPORTED TO BE STABLE POST-REINTERVENTION.
Patient problems: Failure of Implant
MAUDE report 13179247 ↗InjuryApr 20, 2021Patient-Device Incompatibility; Insufficient Device Problem Information; Patient-Device Incompatibility; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT SYSTEM. APPROXIMATELY (3) MONTHS POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A TYPE IB ENDOLEAK, A DISTAL COMMON ILIAC ARTERY DISSECTION, AND ANEURYSM ENLARGEMENT (UNKNOWN DIAMETER). THE PATIENT IS IN GOOD CONDITION, AND THE PHYSICIAN PLANS TO RE-INTERVENE BUT SURGERY HAS NOT BEEN SCHEDULED. NOTE: THE PATIENT HAS SIGNIFICANT PAD (PERIPHERAL ARTERIAL DISEASE) WITH NEARLY OCCLUDED COMMON ILIAC ARTERIES.
Patient problems: Aneurysm; Failure of Implant; Vascular Dissection
MAUDE report 11697134 ↗InjuryJul 24, 2019Unintended Movement; Unintended Movement
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE OVATION IX ABDOMINAL AORTIC ANEURYSM STENT. APPROXIMATELY 2.5 YEARS POST INITIAL PROCEDURE, THE PATIENT PRESENTED EMERGENTLY WITH ABDOMINAL PAIN. THE PHYSICIAN FOUND THAT THE OVATION ILIAC LIMB ON THE PATIENT'S LEFT SIDE HAD PULLED OUT OF THE ILIAC ARTERY AND WAS IN THE AAA WITH A TYPE IB ENDOLEAK PRESENT. THE PHYSICIAN ELECTED TO TREAT THE PATIENT BY IMPLANTING TWO (2) ADDITIONAL ILIAC LIMB OVATION DEVICES ON (B)(6) 2019. THE PATIENT IS REPORTEDLY IN STABLE CONDITION AND A GOOD SEAL WAS ACHIEVED POST RE-INTERVENTION.
Patient problems: Failure of Implant; Pain
MAUDE report 8823634 ↗InjuryJul 3, 2018Partial Blockage; Partial Blockage
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. DURING THE INITIAL PROCEDURE, THERE WAS A POLYMER LEAK REPORTED. ON (B)(6) 2018 WE WERE INFORMED THAT THE PATIENT HAD AN OCCLUDED LIMB AND AN ANGION WAS GOING TO BE PERFORMED. PATIENT RECEIVED A SECONDARY ON (B)(6) 2018 TO ADD AN EXTENDER TO THE RIGHT LIMB TO COVER DISSECTION PLANE. FLOW WAS RE ESTABLISHED, BUT FRESH CLOT FORMED UPON CUT DOWN. PATIENT WAS RECEIVING TPA DRIP IN THE SFA OVERNIGHT. AS OF THIS REPORT, NO ADDITIONAL PATIENT SEQUELAE HAS BEEN REPORTED.
Patient problems: Failure of Implant
MAUDE report 7658746 ↗InjuryJun 18, 2018Unintended Movement; Unintended Movement
ENDOLOGIX BECAME AWARE OF A LEFT LIMB PULLING UP INTO THE ABDOMINAL AORTIC ANEURYSM SAC ON (B)(6) 2018 AS REPORTED BY PHYSICIAN (B)(6) AT (B)(6) MEDICAL CENTER. THE DATE OF EVENT IS ALSO (B)(6) 2018 BASED ON ROUTINE FOLLOW-UP CTA SCAN WHICH DIAGNOSED THE REPORTED MOVEMENT OF THE DISTAL ATTACHMENT SEAL IN THE LEFT COMMON ILIAC. THE PATIENT WAS ORIGINALLY IMPLANTED WITH AN OVATION IX MAIN BODY AND THREE (3) OVATION IX ILIAC LIMBS ON (B)(6) 2017 BY THE REPORTING PHYSICIAN. DURING RE-INTERVENTION, THE PATIENT WAS TREATED BY IMPLANTING AN ADDITIONAL OVATION IX ILIAC LIMB ON (B)(6) 2018 BY PHYSICIAN (B)(6), WHO DETERMINED THAT THE LEFT COMMON ILIAC WAS TOO DISEASED TO LAND, TRAY AND SEAL IN. THE LEFT INTERNAL WAS DISEASED AND STENOTIC AT ITS ORIGIN AS WELL. THE PATIENT IS DOING WELL.
Patient problems: Failure of Implant
MAUDE report 7609372 ↗InjuryMay 22, 2018Occlusion Within Device; Occlusion Within Device
AN OVATION IX ILIAC LIMB STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE PATIENT RETURNED FOR A FOLLOW UP FOR AN UNKNOWN REASON WHERE PHYSICIAN OBSERVED AN INCREASE IN ANEURYSM SIZE AT THE LEFT ILIAC AND A DECREASE IN THE FLOW LUMEN OF THE LEFT ILIAC LIMB. THE PATIENT IS CURRENTLY STABLE AND NO PLANS FOR RE-INTERVENTION HAVE BEEN MADE. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Aneurysm; Occlusion
MAUDE report 7533781 ↗InjuryMay 3, 2017Leak/Splash
AN OVATION IX ABDOMINAL STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. THE 9 MONTH POST-OPERATIVE CT SHOWED THE PRESENCE OF A TYPE 1B ENDOLEAK AT THE RIGHT ILIAC. A RE-INTERVENTION WAS PERFORMED TO IMPLANT AN OVATION ILIAC LIMB EXTENSION EXTENDING THE SEAL INTO THE RIGHT COMMON ILIAC ARTERY, SUCCESSFULLY RESOLVING THE ENDOLEAK. AS OF THE DATE OF THIS REPORT, THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: Aneurysm
MAUDE report 6542827 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page